How Private Credit Is Reshaping Shareholder Liquidity in Hong Kong

Private credit has become one of the defining stories in Asia-Pacific finance, and nowhere is the shift more visible than in Hong Kong. As traditional banks tighten their appetite for concentrated equity exposure, a growing pool of non-bank capital is stepping in to meet demand from shareholders of HKEX-listed companies. For founders, executives and family offices whose wealth is concentrated in listed shares, this matters: the range of liquidity options available to them is wider today than at any point in the past decade.

Why Hong Kong Is the Centre of Gravity

Hong Kong combines three ingredients that make it fertile ground for private credit growth. First, an enormous base of concentrated shareholder wealth: the city hosts more than 3,300 family offices, many built on founding stakes in listed businesses. Second, a revived listing pipeline — the 2026 IPO surge is minting new paper wealth at a pace not seen in years. Third, a banking sector that, for regulatory and risk reasons, is increasingly selective about financing large single-stock positions.

That third point is the gap private credit fills. When a major shareholder of an HKEX-listed company approaches a traditional private bank, the response is often constrained by approved-securities lists, concentration limits and conservative advance rates. Non-bank capital providers can assess the same position on its own merits — the liquidity of the shares, the quality of the underlying business — and structure a facility around it.

Alternative Asset-Backed Lending Comes of Age

Within the broader private credit universe, alternative asset-backed lending — financing supported by real assets and listed securities rather than cash-flow covenants — has grown from a niche into a recognised category. We examined the regional picture in our earlier analysis of Asia-Pacific private credit and the rise of alternative asset-backed lending; in Hong Kong specifically, listed equity has emerged as one of the most efficient forms of collateral in this category.

The logic is straightforward. HKEX blue-chips, H-shares and red chips trade with deep daily liquidity and transparent pricing. A shareholder holding a substantial block can use that position to access capital without selling — avoiding market impact, disclosure noise and the permanent loss of upside that comes with disposal.

What HKEX Shareholders Should Weigh

Not all equity-backed structures are equal, and the growth of the category has brought a wide range of providers into the market. Shareholders evaluating a facility should consider:

Recourse. Non-recourse structures cap the downside at the shares in the facility — there are no personal or corporate guarantees, and other assets stay out of scope. Recourse structures do not offer that separation.

Source of capital. A provider deploying its own balance sheet can commit terms quickly and hold them; intermediated capital can introduce delay and re-trading of terms.

Confidentiality and speed. For executives and substantial shareholders, discretion is often as important as pricing. Direct providers can typically move from enquiry to indicative terms in days.

Our educational guides cover the mechanics in depth, including how equity-backed facilities work for HKEX shareholders and how to compare providers across Asia-Pacific.

Squadron Capital's Position

Squadron Capital has operated in Asia for more than 15 years and deploys direct capital to shareholders of Hong Kong-listed securities — non-recourse facilities from US$1 million to US$100 million, with no personal or corporate guarantees. As private credit reshapes the region's funding landscape, our model remains the same: direct capital, fast decisions, complete discretion. Learn more about equity-backed funding for Hong Kong shareholders or our core equity-backed financing service.